10 August 2022 - Newly diagnosed patients will become the first to access systemic light chain amyloidosis treatment in the UK

The Janssen Pharmaceutical Companies of Johnson & Johnson has welcomed the decision by the SMC to accept Darzalex.

Read Pharma Times article